Predictive Factors of Resistance to High-Dose Steroids Therapy in Acute Attacks of Neuromyelitis Optica Spectrum Disorder-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Predictive Factors of Resistance to High-Dose Steroids Therapy in Acute Attacks of Neuromyelitis Optica Spectrum Disorder

Published:2020-11-12 Issue: Volume:11 Page:
ISSN:1664-2295
Container-title:Frontiers in Neurology
language:
Short-container-title:Front. Neurol.

Author:

Qin Chuan,Tao Ran,Zhang Shuo-Qi,Chen Bo,Chen Man,Yu Hai-Han,Chu Yun-Hui,Shang Ke,Wu Long-Jun,Bu Bi-Tao,Tian Dai-Shi

Funder

National Natural Science Foundation of China

Publisher

Frontiers Media SA

Subject

Clinical Neurology,Neurology

Reference43 articles.

1. A pilot study comparing treatments for severe attacks of neuromyelitis optica spectrum disorders: Intravenous methylprednisolone (IVMP) with add-on plasma exchange (PLEX) versus simultaneous ivmp and PLEX;Songthammawat;Mult Scler Relat Disord.,2019

2. Apheresis therapies for NMOSD attacks: a retrospective study of 207 therapeutic interventions;Kleiter;Neurol Neuroimmunol Neuroinflamm.,2018

3. Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients;Jarius;J Neuroinflam.,2012

4. Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS);Trebst;J Neurol.,2014

5. Beneficial effect of plasma exchange in acute attack of neuromyelitis optica spectrum disorders;Srisupa-Olan;Mult Scler Relat Disord.,2018

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A case report of AQP4-IgG-seropositive refractory neuromyelitis optica spectrum disorder patient with Sjögren’s syndrome and pancytopenia treated with inebilizumab;Frontiers in Neurology;2024-06-05

2. Bickerstaff brain stem encephalitis preceding recurrent myelin oligodendrocyte glycoprotein antibody-associated disease;Acta Neurologica Belgica;2024-03-18

3. A Clinical Approach to Existing and Emerging Therapeutics in Neuromyelitis Optica Spectrum Disorder;Current Neurology and Neuroscience Reports;2023-08-04

4. Efficacy and safety of monoclonal antibodies in neuromyelitis optica spectrum disorders: A survival meta-analysis of randomized controlled trials;Advances in Ophthalmology Practice and Research;2022-11

5. Current view on the diagnosis and treatment of neuromyelitis optica spectrum disorders exacerbations;Neurology, Neuropsychiatry, Psychosomatics;2022-10-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3